ReviewPharmaceutics2024
Personalized Use of Disease-Modifying Therapies in Multiple Sclerosis.
Chi-Yan Lee et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
14 papers cite it
this paperpooled itcites it
ReviewPharmaceutics2024
Chi-Yan Lee et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.